Overview
Emanuela Lavaselli practices in Voghera, Italy. Ms. Lavaselli is rated as an Experienced expert by MediFind in the treatment of Carnitine Palmitoyltransferase 1 Deficiency. Her top areas of expertise are Rhabdomyolysis, Carnitine Palmitoyltransferase 2 Deficiency, Carnitine Palmitoyltransferase 1 Deficiency, and Central Core Disease.
Her clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Carnitine Palmitoyltransferase 1 Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- RhabdomyolysisMs. Lavaselli isAdvanced. Learn about Rhabdomyolysis.
- Experienced
- Carnitine Palmitoyltransferase 1 DeficiencyMs. Lavaselli isExperienced. Learn about Carnitine Palmitoyltransferase 1 Deficiency.
- Carnitine Palmitoyltransferase 2 DeficiencyMs. Lavaselli isExperienced. Learn about Carnitine Palmitoyltransferase 2 Deficiency.
- Central Core DiseaseMs. Lavaselli isExperienced. Learn about Central Core Disease.
- Congenital Fiber-Type DisproportionMs. Lavaselli isExperienced. Learn about Congenital Fiber-Type Disproportion.
- Facioscapulohumeral Muscular Dystrophy (FSHD)Ms. Lavaselli isExperienced. Learn about Facioscapulohumeral Muscular Dystrophy (FSHD).
- Tubular Aggregate MyopathyMs. Lavaselli isExperienced. Learn about Tubular Aggregate Myopathy.